These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 3918468

  • 1. Rapid response to the addition of lithium in iprindole-resistant unipolar depression: a pilot study.
    de Montigny C, Elie R, Caillé G.
    Am J Psychiatry; 1985 Feb; 142(2):220-3. PubMed ID: 3918468
    [Abstract] [Full Text] [Related]

  • 2. Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system.
    de Montigny C, Cournoyer G, Morissette R, Langlois R, Caillé G.
    Arch Gen Psychiatry; 1983 Dec; 40(12):1327-34. PubMed ID: 6418109
    [Abstract] [Full Text] [Related]

  • 3. Lithium augmentation in psychotic depression refractory to combined drug treatment.
    Nelson JC, Mazure CM.
    Am J Psychiatry; 1986 Mar; 143(3):363-6. PubMed ID: 2869701
    [Abstract] [Full Text] [Related]

  • 4. Lithium potentiation of tricyclic antidepressants following lack of T3 potentiation.
    Garbutt JC, Mayo JP, Gillette GM, Little KY, Mason GA.
    Am J Psychiatry; 1986 Aug; 143(8):1038-9. PubMed ID: 3089033
    [Abstract] [Full Text] [Related]

  • 5. Iprindole: a cornerstone in the neurobiological investigation of antidepressant treatments.
    de Montigny C.
    Mod Probl Pharmacopsychiatry; 1982 Aug; 18():102-16. PubMed ID: 6285182
    [No Abstract] [Full Text] [Related]

  • 6. Lithium carbonate augmentation of desipramine in refractory depression.
    Dallal A, Fontaine R, Ontiveros A, Elie R.
    Can J Psychiatry; 1990 Oct; 35(7):608-11. PubMed ID: 2125237
    [Abstract] [Full Text] [Related]

  • 7. Variability of response to lithium augmentation in refractory depression.
    Price LH, Charney DS, Heninger GR.
    Am J Psychiatry; 1986 Nov; 143(11):1387-92. PubMed ID: 3096155
    [Abstract] [Full Text] [Related]

  • 8. [Lithium carbonate augmentation in tricyclic antidepressant-resistant depression].
    Dorevitch A, Ginath Y.
    Harefuah; 1991 Dec 01; 121(11):429-30. PubMed ID: 1786889
    [Abstract] [Full Text] [Related]

  • 9. Lithium in tricyclic-resistant depression. Correlation of increased brain 5-HT function with clinical outcome.
    Cowen PJ, McCance SL, Ware CJ, Cohen PR, Chalmers JS, Julier DL.
    Br J Psychiatry; 1991 Sep 01; 159():341-6. PubMed ID: 1659918
    [Abstract] [Full Text] [Related]

  • 10. Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression.
    Bauer M, Bschor T, Kunz D, Berghöfer A, Ströhle A, Müller-Oerlinghausen B.
    Am J Psychiatry; 2000 Sep 01; 157(9):1429-35. PubMed ID: 10964859
    [Abstract] [Full Text] [Related]

  • 11. Adjunctive lithium carbonate in nortriptyline-resistant elderly depressed patients.
    Zimmer B, Rosen J, Thornton JE, Perel JM, Reynolds CF.
    J Clin Psychopharmacol; 1991 Aug 01; 11(4):254-6. PubMed ID: 1918424
    [Abstract] [Full Text] [Related]

  • 12. Lithium carbonate augmentation of antidepressant treatment. An effective prescription for treatment-refractory depression.
    Heninger GR, Charney DS, Sternberg DE.
    Arch Gen Psychiatry; 1983 Dec 01; 40(12):1335-42. PubMed ID: 6418110
    [Abstract] [Full Text] [Related]

  • 13. Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study.
    Alevizos B, Alevizos E, Leonardou A, Zervas I.
    Psychiatriki; 2012 Dec 01; 23(2):143-8. PubMed ID: 22796912
    [Abstract] [Full Text] [Related]

  • 14. Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study.
    Fava M, Rosenbaum JF, McGrath PJ, Stewart JW, Amsterdam JD, Quitkin FM.
    Am J Psychiatry; 1994 Sep 01; 151(9):1372-4. PubMed ID: 8067495
    [Abstract] [Full Text] [Related]

  • 15. Possible synergism between fluoxetine and lithium in refractory depression.
    Pope HG, McElroy SL, Nixon RA.
    Am J Psychiatry; 1988 Oct 01; 145(10):1292-4. PubMed ID: 3262313
    [Abstract] [Full Text] [Related]

  • 16. Novel antidepressants and the biogenic amine hypothesis of depression. The case for iprindole and mianserin.
    Zis AP, Goodwin FK.
    Arch Gen Psychiatry; 1979 Sep 01; 36(10):1097-1107. PubMed ID: 475543
    [Abstract] [Full Text] [Related]

  • 17. Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders.
    Dé Montigny C, Grunberg F, Mayer A, Deschenes JP.
    Br J Psychiatry; 1981 Mar 01; 138():252-6. PubMed ID: 7272619
    [Abstract] [Full Text] [Related]

  • 18. Increased tonic activation of rat forebrain 5-HT(1A) receptors by lithium addition to antidepressant treatments.
    Haddjeri N, Szabo ST, de Montigny C, Blier P.
    Neuropsychopharmacology; 2000 Apr 01; 22(4):346-56. PubMed ID: 10700654
    [Abstract] [Full Text] [Related]

  • 19. Refractory depression: the addition of lithium to fluoxetine or desipramine.
    Ontiveros A, Fontaine R, Elie R.
    Acta Psychiatr Scand; 1991 Mar 01; 83(3):188-92. PubMed ID: 1903237
    [Abstract] [Full Text] [Related]

  • 20. Lithium augmentation of combined neuroleptic-tricyclic treatment in delusional depression.
    Price LH, Conwell Y, Nelson JC.
    Am J Psychiatry; 1983 Mar 01; 140(3):318-22. PubMed ID: 6131612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.